Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...
Disrupting Biotech: Jurek Kozyra Unveils DNA Nanorobots That Could Cure the Incurable ...
New research has discovered that reducing levels of the STAUFEN-1 protein can prevent neuron death caused by DNA damage and ...
Cholera remains a major global public health challenge, with an estimated 1.3 to 4 million cases and tens of thousands of ...
The "Molecular Biology for the Non-molecular Biologist Training Course (Apr 20th - Apr 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.Elevate your expertise in molecular ...
17hon MSN
New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death
University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...
When brain cells die in diseases like ALS (amyotrophic lateral sclerosis) and frontotemporal dementia, they often activate a ...
Gradalis announces positive results from phase 2b VITAL trial of Vigil to treat patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer: Dallas Friday, January 16, ...
Elevated levels of lipoprotein (a) is a genetic disease that causes cardiovascular disease. Steven Nissen, M.D., addresses why it’s important to find treatments for this genetic risk factor.
The Food Standards Australia New Zealand (FSANZ) approved a virulent purple genetically engineered tomato is a Trojan Horse and threatens NZ biosecurity, and consumer health. [1] The Norfolk Plant ...
A new LUMC study has changed our understanding of how cells work. Researchers have discovered that the CFAP20 protein acts as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results